BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Merck
Colorcon
Novartis
Medtronic
Cerilliant
UBS
Chinese Patent Office
Farmers Insurance

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040766

« Back to Dashboard

NDA 040766 describes HYDROXYCHLOROQUINE SULFATE, which is a drug marketed by Hikma Pharms, Ipca Labs Ltd, Mylan, Sandoz, Teva Pharms, Watson Labs, and Zydus Pharms Usa Inc, and is included in eight NDAs. It is available from twenty-five suppliers. Additional details are available on the HYDROXYCHLOROQUINE SULFATE profile page.

The generic ingredient in HYDROXYCHLOROQUINE SULFATE is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
Summary for 040766
Tradename:HYDROXYCHLOROQUINE SULFATE
Applicant:Ipca Labs Ltd
Ingredient:hydroxychloroquine sulfate
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Pharmacology for NDA: 040766
Medical Subject Heading (MeSH) Categories for 040766
Suppliers and Packaging for NDA: 040766
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040766 ANDA Blenheim Pharmacal, Inc. 10544-578 10544-578-90 90 TABLET, FILM COATED in 1 BOTTLE (10544-578-90)
HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040766 ANDA Rebel Distributors Corp 21695-486 21695-486-30 30 TABLET, FILM COATED in 1 BOTTLE (21695-486-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Jun 14, 2007TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Cantor Fitzgerald
Queensland Health
Healthtrust
UBS
Mallinckrodt
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot